[PRLD] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -16.70%
YoY- 3.84%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -30,431 -27,718 -28,641 -29,958 -27,374 -29,465 -32,842 -4.96%
Tax 239 -1,397 -7,654 -448 -2,087 -823 -168 -
NP -30,431 -26,321 -20,987 -29,510 -25,287 -28,642 -32,842 -4.96%
Tax Rate - - - - - - - -
Total Cost 30,431 26,321 20,987 29,510 25,287 28,642 32,842 -4.96%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.54 -0.55 -0.44 -0.62 -0.53 -0.61 -0.71 -16.72%
EPS Diluted -0.54 -0.55 -0.44 -0.62 -0.53 -0.61 -0.71 -16.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.